Given Imaging Ltd (GIVN) Return on Equity ROE from the to and annually, average high and low, overall ranking from Dec 31 2012 to - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Given Imaging Ltd  (GIVN)

Given Imaging Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Given Imaging Ltd in the ?
Given Imaging Ltd achieved a return on average equity (ROE) of 17.75 % in its , this is above GIVN's average return on equity of 6.44%.
Given Imaging Ltd shareholder's equity over the 12 months ending in its are valued at $148 million

ROE has advanced compared to 12.93% in the , due to net income growth.

Within the Medical Equipment & Supplies industry 35 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the from 0 to 2141.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2012)
FY		 (Dec 31 2011)
FY


Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 26 12 0 0 0
Return On Equity (TTM) 17.75 % 12.93 % 0 % - -
GIVN's Total Ranking # 2141 # 0 # # #
Equity (TTM) in Millions 223 198 173 0 0
Seq. Equity Change 12.81 % 14.38 % - - -
Seq. Net Income Change 19.8 % - - - -

Back to GIVN Management Effectiveness >> GIVN's 5 Years Annual ROE >> Compare GIVN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 36
Sector # 119
Overall # 2141

Return On Equity Statistics
High Average Low
6.44 %
6.44 %
6.44 %
 





GIVN Annual Return On Equity (Dec 31 2012)
2012		 (Dec 31 2009)
2011


Total Equity in Millions 223 198 0 0 0
Y / Y Equity Change 12.81 % - - - -
Net Income in Millions 14 12 0 0 0
Y / Y Net Income Change 19.8 % - - - -
Return On Equity 6.44 % 6.06 % - - -

Back to GIVN Management Effectiveness >> GIVN's 5 Years Annual ROE >> Compare GIVN ROE to its Competitors




Annual Roe Comment
In 2012 ROE improved to 6.44 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GIVN's' Return on Equity at Yahoo Finance
GIVN's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GIVN's Competitors
Subscribers only: Roe for Given Imaging Ltd's Suppliers
Subscribers only: Return On Equity for GIVN's Customers




Companies with similar Return On Equity at Dec 31 2012, within Healthcare Sector ROE
Cambrex Corp  48.40 %
Durect Corp  48.31 %
Sunlink Health Systems Inc   39.65 %
Mettler toledo International Inc   36.27 %
Spectrum Pharmaceuticals Inc   34.90 %
Waters Corporation  34.52 %
Baxter International Inc   34.03 %
Abbvie Inc   32.91 %
Jazz Pharmaceuticals Plc  31.88 %
Gilead Sciences Inc   30.50 %
United Therapeutics Corporation  30.18 %
Idexx Laboratories Inc  29.58 %
China Health Industries Holdings Inc   28.16 %
Varian Medical Systems Inc   28.06 %
Bard C R Inc  27.84 %
Eli Lilly And Company  27.27 %
Becton Dickinson And Company  26.83 %
Psychemedics Corporation  26.23 %
China Biologic Products Holdings Inc   25.63 %
3m Company  25.51 %
Celgene Corp  25.44 %
Nrc Health  25.08 %
Meridian Bioscience Inc   25.06 %
Nature s Sunshine Products inc   23.84 %
Option Care Health Inc   23.82 %
Abbott Laboratories  23.59 %
Davita Inc   23.00 %
Community Health Systems Inc   22.61 %
Precision Optics Corporation Inc   22.52 %
Agilent Technologies inc   21.91 %

Date modified: 2026-09-02T20:31:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.